Cleveland BioLabs Reports Third Quarter 2017 Financial Results and Development Progress
November 14, 2017 08:15 ET
|
Cleveland BioLabs, Inc.
BUFFALO, NY--(Marketwired - Nov 14, 2017) - Cleveland BioLabs, Inc. (NASDAQ: CBLI) today reported financial results and development progress for the third quarter ended September 30, 2017.
...
Cleveland BioLabs Reports Second Quarter 2017 Financial Results and Development Progress
August 14, 2017 08:12 ET
|
Cleveland BioLabs, Inc.
BUFFALO, NY--(Marketwired - Aug 14, 2017) - Cleveland BioLabs, Inc. (NASDAQ: CBLI) today reported financial results and development progress for the second quarter ended June 30, 2017.
...
Cleveland BioLabs Reports First Quarter 2017 Financial Results and Development Progress
May 15, 2017 07:30 ET
|
Cleveland BioLabs, Inc.
BUFFALO, NY--(Marketwired - May 15, 2017) - Cleveland BioLabs, Inc. (NASDAQ: CBLI) today reported financial results and development progress for the first quarter ended March 31, 2017.
...
Cleveland BioLabs Announces Commencement of In Vivo Biocomparability Study
April 17, 2017 07:36 ET
|
Cleveland BioLabs, Inc.
BUFFALO, NY--(Marketwired - Apr 17, 2017) - Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced that the U.S. Food and Drug Administration (FDA) has completed its review of a side-by-side...
Cleveland BioLabs Announces European Medicines Agency Positive Opinion Regarding the Entolimod Pediatric Investigation Plan
April 17, 2017 07:30 ET
|
Cleveland BioLabs, Inc.
BUFFALO, NY--(Marketwired - Apr 17, 2017) - Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced that the European Medicines Agency (EMA) has accepted the company's pediatric investigation...
Cleveland BioLabs Announces Webcast of Annual Meeting
April 11, 2017 17:00 ET
|
Cleveland BioLabs, Inc.
BUFFALO, NY--(Marketwired - Apr 11, 2017) - Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced that the Company will webcast its 2017 Annual Meeting of Stockholders on April 21, 2017 at...
Cleveland BioLabs Reports 2016 Financial Results and Development Progress
February 22, 2017 16:15 ET
|
Cleveland BioLabs, Inc.
BUFFALO, NY--(Marketwired - Feb 22, 2017) - Cleveland BioLabs, Inc. (NASDAQ: CBLI) today reported financial results and development progress for the fourth quarter and year ended December 31, 2016....
Cleveland BioLabs Reports Third Quarter 2016 Financial Results and Development Progress
November 14, 2016 07:30 ET
|
Cleveland BioLabs, Inc.
BUFFALO, NY--(Marketwired - Nov 14, 2016) - Cleveland BioLabs, Inc. (NASDAQ: CBLI) today reported financial results and development progress for the third quarter ended September 30, 2016.
...
Cleveland BioLabs Announces a $1.1 Million Cost Realignment With the Department of Defense
October 11, 2016 08:45 ET
|
Cleveland BioLabs, Inc.
BUFFALO, NY--(Marketwired - Oct 11, 2016) - Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced that the Department of Defense (DoD) has modified its Joint Warfighter Medical Research Program...
Cleveland BioLabs Reports Second Quarter 2016 Financial Results and Development Progress
August 15, 2016 08:30 ET
|
Cleveland BioLabs, Inc.
BUFFALO, NY--(Marketwired - Aug 15, 2016) - Cleveland BioLabs, Inc. (NASDAQ: CBLI) today reported financial results and development progress for the second quarter ended June 30, 2016.
...